PINK1-induced mitophagy promotes neuroprotection in Huntington's disease

B Khalil1, N El Fissi2, A Aouane2

  • 1Aix-Marseille Université, CNRS, Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille, UMR 7286, 13344 Marseille, France.

Cell Death & Disease
|January 23, 2015
PubMed

Insights

Huntington's disease involves impaired mitochondrial quality control. Boosting the PINK1/Parkin pathway in flies and mice improved mitochondrial function and neuronal survival, offering a potential therapeutic strategy for this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Huntington's disease (HD) is a fatal neurodegenerative disorder linked to CAG repeat expansion in the huntingtin gene.
  • Mutant huntingtin (mHtt) disrupts cellular processes, with impaired mitochondrial metabolism playing a key role in HD pathogenesis.
  • Mitochondrial dysfunction and abnormal morphology, including spheroid formation, are observed in HD models.

Purpose of the Study:

  • To investigate the role of mitochondrial damage and mitophagy in Huntington's disease using a Drosophila model.
  • To explore the therapeutic potential of enhancing the PTEN-induced putative kinase 1 (PINK1)/Parkin mitophagy pathway in HD.

Main Methods:

  • Utilized the Drosophila model to analyze mHtt's impact on mitochondrial morphology and mitophagy.
  • Investigated the role of PINK1 and Parkin in mHtt-induced mitochondrial defects.
  • Examined mitophagy and PINK1/Parkin pathway activity in HD striatal cells from HdhQ111 knock-in mice.

Main Results:

  • Discovered abnormal ring-shaped mitochondria in HD flies, linked to impaired mitophagy.
  • Demonstrated that PINK1 overexpression alleviated mitochondrial abnormalities, improved ATP levels, neuronal integrity, and fly survival in an HD model.
  • Showed that PINK1-mediated neuroprotection was Parkin-dependent and required specific mitochondrial proteins.
  • Confirmed impaired mitophagy in HD mouse striatal cells and partial restoration by PINK1 overexpression.
  • Found that mHtt impairs mitochondrial targeting to autophagosomes but not ubiquitination.

Conclusions:

  • Mitophagy is significantly altered in the presence of mutant huntingtin.
  • Enhancing the PINK1/Parkin mitochondrial quality control pathway offers a promising therapeutic strategy for improving mitochondrial integrity and neuroprotection in Huntington's disease.